Melissa Raspa
Biographic Data
| ID | 6764022 |
|---|---|
| NAME | Melissa Raspa |
| GIVEN NAMES | Melissa |
| FAMILY NAME | Raspa |
| SIGNATURE | RASPA M |
| AFFILIATIONS | RTI International |
| ORCID | 0000-0003-3791-3367 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
An evaluation of U.S. federal investments in newborn screening
Introduction: Newborn screening (NBS) is a successful public health program conducted by states that provides screening, confirmatory testing, and access to treatments for millions of babies each year. Federal legislation has outlined activities to support the newborn screening system. This paper summarizes an evaluation of investments made by the Health Resources and Services Administration's (HRSA) within the U.S. Department of Health and Human…
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome
Advances in understanding neurobiology and intellectual disabilities have led to clinical trials testing new medications. This study assessed parents' perceptions of the ability of their son or daughter with fragile X syndrome (FXS), an inherited form of intellectual disability, to participate in the consent process for clinical trials. Four hundred twenty-two families participated in a survey that included six items assessing various aspects of …
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome
Advances in understanding neurobiology and intellectual disabilities have led to clinical trials testing new medications. This study assessed parents' perceptions of the ability of their son or daughter with fragile X syndrome (FXS), an inherited form of intellectual disability, to participate in the consent process for clinical trials. Four hundred twenty-two families participated in a survey that included six items assessing various aspects of …
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome
Advances in understanding neurobiology and intellectual disabilities have led to clinical trials testing new medications. This study assessed parents' perceptions of the ability of their son or daughter with fragile X syndrome (FXS), an inherited form of intellectual disability, to participate in the consent process for clinical trials. Four hundred twenty-two families participated in a survey that included six items assessing various aspects of …
An evaluation of U.S. federal investments in newborn screening
Introduction: Newborn screening (NBS) is a successful public health program conducted by states that provides screening, confirmatory testing, and access to treatments for millions of babies each year. Federal legislation has outlined activities to support the newborn screening system. This paper summarizes an evaluation of investments made by the Health Resources and Services Administration's (HRSA) within the U.S. Department of Health and Human…
Alternative medicine (1 work) · Autism Spectrum Disorder Research (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Clinical trial (1 work) · Daughter (1 work) · Developmental psychology (1 work) · Ethics and Legal Issues in Pediatric Healthcare (1 work) · Fragile X syndrome (1 work) · Genetics and Neurodevelopmental Disorders (1 work)